HoneyNaps

AI-based virtual staining of tissue samples to replace traditional dyes, in theory enabling faster and more accurate diagnosis

Undisclosed · $30M · 2024-09

Mira (Quanovate Tech Inc.) is a US women's health technology company that makes the Mira at-home hormone monitor, which pairs disposable test wands with an AI-powered app to track LH, E3G, PdG and FSH for fertility, PCOS and perimenopause. It is FDA-registered and Health Canada licensed, with users in 40+ countries.

$5M

Precision oncology diagnostics: integrated molecular profiling of tumors across DNA/RNA/protein layers, assessing actionable targets across tumor types, target heterogeneity and resistance mechanisms, benchmarked against large tumor datasets, delivered to physicians and patients as interactive software + shareable data (not static PDF reports)

Seed · $14M · 2026-04

AI + digital pathology focused on core diagnostic needs: full-chain digital pathology department solutions incl. smart scanning, QC and multi-cancer analysis; develops the DeepPathAI pathology model.

Series C · 2026-07

AI-based pathology image diagnosis services

Series A · $69M · 2024-06

AI sleep health screening and brainwave intervention (smartphone face-scan screening + brainwave eye mask)

AI-based blood tests for cancer detection

Series A · $11M · 2025-01

AI tool that assists skin cancer detection by identifying skin lesions from images

Series B · $20M · 2025-04

Early breast cancer screening devices using saliva samples and AI

Seed · $4M · 2025-07

Uses AI to analyze pathology images for medical research and clinical diagnosis

Undisclosed · $14M · 2024-04

AI platform to improve the accuracy and efficiency of point-of-care ultrasound diagnosis

Seed · $13M · 2024-05

Incubated by the Paris Brain Institute; AI-based eye-tracking diagnosis of neurodegenerative diseases

Undisclosed · $5M · 2024-05